Many small steps towards a COVID-19 drug

A large-scale screening campaign has yielded dozens of crystal structures of small molecule fragments that bind to the main protease of SARS-CoV-2. The global research community is encouraged to pursue these as drug discovery starting points for COVID-19.

Detalles Bibliográficos
Autor principal: Erlanson, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541474/
https://www.ncbi.nlm.nih.gov/pubmed/33028832
http://dx.doi.org/10.1038/s41467-020-18710-3
Descripción
Sumario:A large-scale screening campaign has yielded dozens of crystal structures of small molecule fragments that bind to the main protease of SARS-CoV-2. The global research community is encouraged to pursue these as drug discovery starting points for COVID-19.

Ejemplares similares